Legal & General Group Plc Has $372 Million Stock Holdings in Corteva, Inc. $CTVA

Legal & General Group Plc lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 3.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 5,549,753 shares of the company’s stock after selling 204,229 shares during the period. Legal & General Group Plc owned 0.82% of Corteva worth $372,000,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Activest Wealth Management grew its holdings in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the period. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter worth $25,000. Redmont Wealth Advisors LLC bought a new position in shares of Corteva during the third quarter worth $29,000. Jackson Grant Investment Advisers Inc. boosted its position in shares of Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of Corteva during the third quarter worth $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $79.20 on Wednesday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm has a market capitalization of $52.97 billion, a P/E ratio of 46.59, a P/E/G ratio of 2.43 and a beta of 0.59. The company’s 50 day moving average price is $81.32 and its two-hundred day moving average price is $74.27.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business posted $1.13 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analyst Ratings Changes

CTVA has been the topic of a number of recent analyst reports. The Goldman Sachs Group lifted their price target on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Berenberg Bank upped their target price on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Argus upped their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Finally, BNP Paribas Exane upped their target price on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.14.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.